Incannex Healthcare (IXHL) Research & Development (2022 - 2026)
Incannex Healthcare (IXHL) recorded Research & Development of $1.49 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 59.8% from $3.7 million a year earlier but up 363.9% from the prior quarter.
Powered by 
Analysis
Incannex Healthcare (IXHL) Research & Development (2022 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Incannex Healthcare reported Research & Development of $5.21 million, down 51.5% from FY2025.
- Annual Research & Development has a five-year compound annual growth rate of 1.9% (FY2021 to FY2026).
- Across earlier fiscal years, Research & Development came in at $10.75 million in FY2025 (-16.6%), $12.88 million in FY2024 (+104.1%), $6.31 million in FY2023 (+17.4%) and $5.37 million in FY2022 (+13.1%).
- Quarterly Research & Development has ranged from $321,000 in fiscal Q3 2026 to $4.36 million in fiscal Q4 2024 over the past five years.
- On a year-over-year basis, Research & Development rose in two of the last eight quarters, with an average decline of 26.9%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 154.6% in fiscal Q4 2024, against a decline of 88.3% in fiscal Q3 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $321,000 (Q3 2026), $2.28 million (Q2 2026) and $1.12 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Incannex Healthcare | 39.52 Mn | 39.52 Mn | - | 1.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 Mn |
| Mar 31, 2026 | 321,000.00 |
| Dec 31, 2025 | 2.28 Mn |
| Sep 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 3.70 Mn |
| Mar 31, 2025 | 2.74 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 4.36 Mn |
| Mar 31, 2024 | 3.28 Mn |
| Dec 31, 2023 | 2.64 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 1.71 Mn |
| Mar 31, 2023 | 1.64 Mn |
| Dec 31, 2022 | 1.55 Mn |
API Access
Incannex Healthcare Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=IXHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "IXHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=IXHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();